Transgender women have several reproductive options depending on their transition stage, fertility status, and personal circumstances. These include unassisted conception, intrauterine insemination (IUI), and in vitro fertilization (IVF), either with a partner who has a uterus or with a gestational carrier. While uterine transplants may one day allow trans women to carry pregnancies, this remains experimental and years away.
Unassisted conception is possible if estrogen therapy has not begun or after temporarily stopping hormones, though natural conception rates are typically low. IUI, which involves inserting sperm directly into a partner’s uterus, may work if sperm was banked before transition or if enough sperm can be produced after pausing hormone therapy. Success depends largely on the carrier’s age and overall fertility.
IVF involves fertilizing eggs in a lab and transferring embryos to the uterus. It’s costly and may require multiple cycles, but donor eggs or sperm can improve success rates. Fertility preservation before transition remains the best strategy for future family planning.
A gender-affirming transition, including hormone therapy and surgery, can significantly affect fertility. It’s best to consider these impacts before beginning the transition process.
During transition, many trans women take estrogen and/or androgen blockers. Estrogen can severely reduce or even permanently damage sperm production. In some cases, sperm production may partially recover after stopping estrogen for three to six months, but the amount is usually very small. As a result, natural conception is unlikely, and assisted reproductive technologies such as intrauterine insemination (IUI) or in vitro fertilization (IVF) are often required.
There is limited research on how long one should discontinue estrogen to regain sperm or how exposure duration affects recovery. Since a sperm production cycle takes about three months, providers typically suggest waiting at least that long.
Gender-affirming surgeries that involve removing the testes permanently end fertility unless sperm or testicular tissue is preserved beforehand.
Fertility preservation is an important consideration for transgender women, as hormones like estrogen can significantly reduce fertility, and surgeries that remove the testes permanently eliminate sperm production. Preserving fertility before transition greatly increases the chances of future conception through treatments like IUI or IVF.
The ideal time to consider fertility preservation is before starting hormone therapy, though options may still exist afterward. Studies show that even before transition, trans women often have lower sperm counts and quality compared to cisgender men, making semen analysis essential before freezing sperm.
The most common method is sperm freezing, which costs around $400–$1,000, with annual storage fees. Freezing multiple samples improves future treatment options and reduces the need for emotionally difficult “de-transitioning.”
Mail-in sperm freezing kits offer privacy, though medical follow-up is still needed. For those unable to ejaculate, experimental testicular tissue freezing may one day make laboratory-grown sperm possible, offering hope for future IVF use.
Our job is to listen, to connect the dots between your needs, and to determine how we can best help you have your baby. If you’re asking how much does it cost for a surrogate, we’ll walk you through every step of the process to ensure there are no surprises.
To make an appointment with one of our counselors or physicians, please call (212) 661-7673 or email info@surrogacy4all.com. We look forward to hearing from you.
Secret Guide to Minimizing Surrogacy Costs
All Rights Reserved to Surrogacy4all
RESOLVE: The National Infertility Association, established in 1974, is dedicated to ensuring that all people challenged in their family building journey reach resolution through being empowered by knowledge, supported by community, united by advocacy, and inspired to act.
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers.
Welcome to the Parent Guide: Starting Life Together, for children and their caregivers. Whether you are a mother or father (through birth, adoption, or foster care), a grandparent, partner, family friend, aunt or uncle with parenting responsibilities, the Parent Guide has information to help you through the FIRST FIVE YEARS of your parenting journey.
Path2Parenthood (P2P) is an inclusive organization committed to helping people create their families of choice by providing leading-edge outreach programs.
The FDA is a part of the Department of Health and Human Services.
Each day in America, you can trust the foods you eat and the medicines you take, thanks to the U.S. Food and Drug Administration.